SCHEMBL8064773

SCHEMBL8064773

Cc1cc(C)cc(C(=O)CNCC(CCBr)c2ccc(Cl)c(Cl)c2)c1

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MCHR1 Q99705 1/20 0.35
HPGD P15428 1/20 0.34
S1PR2 O95136 2/20 0.34
S1PR4 O95977 2/20 0.34
S1PR3 Q99500 2/20 0.34
CYP26A1 O43174 1/20 0.34
TACR1 P25103 1/20 0.34
ITGAV P06756 1/20 0.33
S1PR1 P21453 1/20 0.33
TACR2 P21452 1/20 0.33
PRKCZ Q05513 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8064776 1.00 ALDH1A1 (0.36) ALDH1A1LMNAHTTSMN1; SMN2MCHR1
SCHEMBL8561489 0.90 HTT (0.37) ALDH1A1LMNAHTTSMN1; SMN2MCHR1
SCHEMBL8561494 0.90 HTT (0.37) ALDH1A1LMNAHTTSMN1; SMN2MCHR1
SCHEMBL8878961 0.88 UTS2R (0.37) LMNAITGAV
SCHEMBL8559422 0.88 UTS2R (0.37) LMNAITGAV
SCHEMBL8053257 0.85 ALDH1A1 (0.37) ALDH1A1LMNAHTTSMN1; SMN2HPGD
SCHEMBL8063808 0.85 ALDH1A1 (0.37) ALDH1A1LMNAHTTSMN1; SMN2HPGD
SCHEMBL8565826 0.84 MCHR1 (0.42) ALDH1A1MCHR1TACR1TACR2
SCHEMBL8882416 0.84 MCHR1 (0.42) ALDH1A1MCHR1TACR1TACR2
SCHEMBL8580535 0.76 S1PR2 (0.43) ALDH1A1LMNAHTTSMN1; SMN2MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6013652-A ANTIINFLAMMATORY AGENTS; ANALGESICS; ANTIHISTAMINES MERCK & CO., INC. (US) 2000-01-11 US disclosed
US-5962462-A COMPOUNDS WHICH INHIBIT THE ENTRY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTO TARGET CELLS; DELAYING THE ONSET OF ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS). MERCK & CO., INC. (US) 1999-10-05 US disclosed
EP-0783498-A4 SUBSTITUTED ARYL PIPERAZINES AS NEUROKININ ANTAGONISTS MERCK & CO INC (US) 1998-04-15 EP disclosed
EP-0783498-A1 SUBSTITUTED ARYL PIPERAZINES AS NEUROKININ ANTAGONISTS MERCK & CO. INC. (US) 1997-07-16 EP disclosed
US-5607936-A USEFUL IN TREATMENT OF RESPIRATORY DISEASES MERCK & CO., INC. (US) 1997-03-04 US disclosed
WO-1996010568-A1 SUBSTITUTED ARYL PIPERAZINES AS NEUROKININ ANTAGONISTS MERCK & CO., INC. (US) 1996-04-11 WO disclosed
EP-0702681-A1 SPIRO-SUBSTITUTED AZACYCLES AS NEUROKININ ANTAGONISTS MERCK & CO. INC. (US) 1996-03-27 EP disclosed
WO-1994029309-A1 SPIRO-SUBSTITUTED AZACYCLES AS NEUROKININ ANTAGONISTS MERCK & CO., INC. (US) 1994-12-22 WO disclosed